Johnson & Johnson is a multinational company specializing in healthcare and pharmaceuticals. With a vast range of products, from prescription medicines, medical devices to baby care items, J&J has a global presence in the health sector.
About Johnson & Johnson (JNJ)
Established in 1886 by three brothers, Robert Wood Johnson, James Wood Johnson, and Edward Mead Johnson in New Brunswick, New Jersey, not many realize that behind the product lines we recognize today, there’s a history of over a century of perseverance and innovation. Starting from creating the first sterile bandage for wounds in the 1890s, Johnson & Johnson has evolved into a multinational enterprise reaching over 60 countries.
With over 130,000 employees worldwide, JNJ has successfully built a reputation as one of the largest and most trusted companies in healthcare. Committed to quality, innovation, and integrity, the company continues to lead the market across various health sectors, including baby care, wound care, and even surgeries.
Johnson & Johnson doesn’t just focus on business but also upholds its social responsibilities. Through sustainability programs, they aim to minimize environmental impacts and give back to communities through diverse public health initiatives.
Vision and Mission of Johnson & Johnson (JNJ)
Johnson & Johnson’s vision is to transform global health for future generations. Prioritizing global health needs, the company aspires to create a world where every individual can live healthily without concerns about the quality of their healthcare.
Their mission is to innovate to meet the health needs of every individual. Leveraging advanced science and technology, Johnson & Johnson dedicates itself to delivering effective, safe, and affordable healthcare solutions for all.
The company’s commitment extends not only to their products but also to their business practices. By emphasizing integrity, transparency, and sustainability, Johnson & Johnson aims to make a positive impact on societies and environments worldwide.
Main Products of Johnson & Johnson (JNJ)
1. Baby Care
Johnson & Johnson’s baby care products have always been a favorite among young mothers. With a gentle and safe formula, millions of mothers globally have relied on these products for their children’s care.
2. Skin Care Products
Offering a variety of quality skin care products, Johnson & Johnson provides solutions for various skin issues. From moisturizers to anti-aging products, millions trust these products to maintain their skin’s beauty and health.
3. Surgical and Medical Devices
Introducing cutting-edge technology in surgery, Johnson & Johnson stands as a leader in providing surgical tools and other medical equipment. With a commitment to innovation and patient safety, their products are used in thousands of hospitals and clinics worldwide.
Key Figures Behind Johnson & Johnson’s Success (JNJ)
Behind a company’s success are individuals with immense dedication and visionary outlooks. In Johnson & Johnson’s history, several names stand out:
1. Robert Wood Johnson I
Robert Wood Johnson I, one of the three founders of Johnson & Johnson, was a visionary who grasped the need for sterile wound care. In the late 19th century, seeing numerous war victims dying from wound infections, Johnson took the initiative to develop the first sterile bandage.
Due to his determination, the concept of sterilization in medical care became widely known and accepted. Without his efforts, the healthcare industry might not have flourished as it does today.
2. Alex Gorsky
As the current CEO, Alex Gorsky plays a crucial role in maintaining public trust in JNJ. Under his leadership, the company has achieved various milestones, including the development of innovative medical products and global expansion. With a military background and his extensive experience at JNJ, Gorsky is committed to making healthcare accessible to the global populace.
3. Dr. Paul Janssen
Dr. Paul Janssen, founder of Janssen Pharmaceutica, which later became part of JNJ, was a gifted scientist who developed over 80 drugs throughout his career. One of his most significant contributions was the development of medications for mental health issues, including antipsychotics and antidepressants. His work transformed the way the world understands and treats mental health disorders.
Stock Price Fluctuations of Johnson & Johnson (JNJ)
Since its initial stock listing, JNJ has experienced various ups and downs. However, there have been moments where its stock price fluctuations truly captured the world’s attention.
One of the biggest controversies JNJ faced was the allegation in the 2010s that their talcum powder contained asbestos, a carcinogenic substance. This had a significant impact on JNJ’s stock price, which saw a sharp decline. Even though JNJ consistently denied these claims, public trust was momentarily tarnished.
Amidst the pandemic, JNJ acted swiftly by developing a COVID-19 vaccine. When their vaccine received emergency approval from various global health regulators, JNJ’s stock price surged. However, reports about rare side effects caused their stock price to fluctuate again.
With multiple discoveries and medical product developments, JNJ’s stock price continued to rise throughout the 1990s to the 2000s. They succeeded in developing drugs that provided solutions for various diseases, leading investors and the market to be highly optimistic about the company’s future.
History and Development of Johnson & Johnson (JNJ)
When Robert Wood Johnson I met a doctor during his travels and heard about the need for sterile bandages, that monumental idea birthed Johnson & Johnson. In 1886, along with his two brothers, James and Edward, they founded the company in New Brunswick, New Jersey. One of their first products was a sterile bandage, which at the time was a revolution in the medical world and reduced death rates from infections.
Entering the early 20th century, JNJ continued to innovate by launching new products, including the first dental floss and Band-Aid®, which remains an iconic brand to this day. Beyond just manufacturing, JNJ also concentrated on research and development, eventually elevating the company to the global stage. In the 1950s, the company expanded outside the United States, opening its first branches in Canada and the UK.
Entering the digital era, JNJ didn’t want to be left behind. The company began investing in health information technology and collaborated with tech startups to create technology-based health solutions. From wearable devices to health apps, JNJ is committed to integrating digital innovation into its health ecosystem.
Like many other major companies, JNJ faced various challenges, ranging from legal issues, product controversies, to global market challenges. However, with strong management and a long-term vision, the company managed to weather the storms and has maintained its reputation as a global healthcare industry leader.
Today, with a presence in over 60 countries and products sold in more than 175 countries, JNJ continues to dedicate itself to addressing the health challenges of today and the future. With a combination of tradition, innovation, and commitment, Johnson & Johnson stands firm as a beacon in the global healthcare industry.
|Headquarters||New Brunswick, New Jersey, United States|
|Number of employees||152,700|
|Total Revenue||94,94 M||93,78 M||82,58 M||82,06 M|
|Cost of Revenue||31,09 M||29,86 M||28,43 M||27,56 M|
|Gross Profit||63,85 M||63,92 M||54,16 M||54,50 M|
|Operating Income||23,70 M||24,55 M||19,91 M||20,97 M|
|Operating Expense||40,15 M||39,37 M||34,24 M||33,53 M|
|Net Income||17,94 M||20,88 M||14,71 M||15,12 M|
|Total Assets||187,38 M||182,02 M||174,89 M||157,73 M|
|Total Liabilities||110,57 M||108,00 M||111,62 M||98,26 M|
|Total Equity||76,80 M||74,02 M||63,28 M||59,47 M|
|Operating Cash Flow||21,19 M||23,41 M||23,54 M||23,42 M|
|Investing Cash Flow||-12,37 M||-8,68 M||-20,83 M||-6,13 M|
|Financing Cash Flow||-8,87 M||-14,05 M||-6,12 M||-18,02 M|
|End Cash Position||14,13 M||14,49 M||13,99 M||17,31 M|
in USD (Jt = million, M = billion, T = trilion)
|Joaquin Duato||CEO & Chairman|
|Joseph J. Wolk CPA||Exec. VP & CFO|
|Ashley A. McEvoy||Exec. VP & Worldwide Chairman of MedTech|
|Jennifer L. Taubert||Exec. VP & Worldwide Chairman of Pharmaceuticals|
|Robert J. Decker Jr.||Controller & Chief Accounting Officer|
|John C. Reed M.D., Ph.D.||Exec. VP of Pharmaceuticals R&D|
|James Swanson||Exec. VP & Chief Information Officer|
|Jessica Moore||VP of Investor Relations|
|Dirk Brinckman||Chief Compliance Officer|
How to Buy Johnson & Johnson (JNJ) Stocks
Interested in buying shares of this tech company? You can buy Johnson & Johnson (JNJ) shares with simple steps:
- Install Nanovest app on the App Store or Play Store.
- Register according to the instructions.
- Verify your identity for security and convenience when buying stocks through the KYC feature which you can do in just 1 minute.
- Top Up your balance to your Nanovest account.
- Go to the stock menu, search and select Johnson & Johnson (JNJ).
- Click the Buy button and confirm the purchase with your desired amount. You can start with only IDR 5,000.
Before investing in the stocks you want, do some research and analysis first. You can do this by checking company profile, industry conditions, company financial reports, and analyzing previous stock price movements. This analysis is important so that you can develop an accurate investment strategy and minimize losses.
Is it Safe to Buy Johnson & Johnson (JNJ) Stocks on Nanovest?
Of course. Nanovest is supported by a number of professional partners who have a good reputation in providing their services. One of them is supported by S-Quantum Engine technology by Sinarmas Financial Services.
For global and US stocks, Nanovest partners with brokers registered with the United Stated Financial Industry Regulatory Authority (FINRA) – which insures brokerage accounts held by Nanovest users up to U$S 500k by the United States Securities Investor Protection Corporation (SIPC).
For crypto assets, Nanovest is registered with the Commodity Futures Trading Supervisory Agency (Bappebti). The Nanovest platform itself has also been insured through a partnership with Sinarmas Insurance.
All content on this website is for informational purposes and doesn’t constitute a recommendation to buy/sell any stock or digital asset. Investors should understand the nature of stocks and digital assets, including return and risk requirements of the assets. We encourage investors to fully understand the assets and risks before making any investment. Always do your own research.
See More Stocks
- Netflix, Inc. (NFLX) Stocks
- Meta Platforms, Inc. (META) Stocks
- Alphabet Inc. Class C (GOOG) Stocks
- Spotify Technology SA (SPOT) Stocks
- Amazon.com, Inc. (AMZN) Stocks
- Intel Corporation (INTC) Stocks
- Apple Inc. (AAPL) Stocks
- Microsoft Corporation (MSFT) Stocks
- Tesla, Inc. (TSLA) Stocks
- Alibaba Group (BABA) Stocks
- Visa Inc. (V) Stocks
- Citigroup Inc. (C) Stocks
- JPMorgan Chase & Co (JPM) Stocks
- HSBC Holdings plc (HSBC) Stocks
- Chevron Corporation (CVX) Stocks
- General Motors Co (GM) Stocks